COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee
Open Access
- 1 February 2021
- journal article
- research article
- Published by Elsevier BV in World Allergy Organization Journal
- Vol. 14 (2), 100517
- https://doi.org/10.1016/j.waojou.2021.100517
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Vaccination and allergy: EAACI position paper, practical aspectsPediatric Allergy and Immunology, 2017
- Vaccination management in children and adults with mastocytosisClinical & Experimental Allergy, 2017
- Polyethylene glycol as a cause of anaphylaxisAllergy, Asthma & Clinical Immunology, 2016
- Immediate‐type hypersensitivity to polyethylene glycols: a reviewClinical & Experimental Allergy, 2016
- International Consensus (ICON): allergic reactions to vaccinesWorld Allergy Organization Journal, 2016
- Risk of anaphylaxis after vaccination in children and adultsJournal of Allergy and Clinical Immunology, 2015
- Anaphylaxis as an adverse event following immunisation in the UK and IrelandArchives of Disease in Childhood, 2012
- Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent processMolecular Immunology, 2008
- Anaphylaxis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety dataVaccine, 2007
- Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic productsToxicology, 2005